VCYT (Veracyte) GF Score: 75/100 (As of Jun. 26, 2026) — Near Median


VCYT Veracyte Inc VCYT
75 GF Score
Price $58.59
GF Value $38.11
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Veracyte GF Score?

Veracyte VCYT +3.15% 75 GF Score is 75 as of Jun. 26, 2026, which is 7% above its 10-year median of 70.00. GuruFocus rates VCYT with a GF Score™ of 75/100 and a GF Value™ of $38.11 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Veracyte has the GF Score of 75, which implies that the company is Likely to have average performance.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 4/10
3. Growth Rank : 8/10
4. GF Value Rank : 3/10
5. Momentum Rank : 10/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Veracyte is Likely to have average performance.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Veracyte  (NAS:VCYT) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Veracyte GF Score Related Terms

VCYT vs TWST, GRAL, RDNT: GF Score Comparison

For the Diagnostics & Research subindustry, Veracyte's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veracyte GF Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Veracyte's GF Score distribution charts can be found below:

* The bar in red indicates where Veracyte's GF Score falls into.


VCYT
75GF Score
Veracyte Inc VCYT
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 75 mean?
Veracyte (VCYT) has a GF Score of 75 as of Jun. 26, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Veracyte and its competitors. This is near median its historical median of 70.00. Over the past decade, Veracyte's GF Score has ranged from 18.00 to 86.00.
Is Veracyte's GF Score too high?
Veracyte's current GF Score of 75 is near median its 10-year median of 70.00. Over the past 10 years, this metric has ranged from a low of 18.00 to a high of 86.00. Overall, Veracyte has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Veracyte's GF Score compare to TWST and GRAL?
Veracyte's GF Score of 75 can be compared against companies in the Medical Diagnostics & Research industry. Historically, Veracyte's own GF Score has ranged from 18.00 to 86.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Diagnostics & Research company?
A good GF Score depends on the Medical Diagnostics & Research industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Veracyte and its competitors. Veracyte's current GF Score is 75, which is near median its own 10-year median of 70.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veracyte stock overvalued right now?
Based on GuruFocus' analysis, Veracyte (VCYT) is currently considered Significantly Overvalued. The stock's GF Value™ is $38.11, compared to a current price of $58.59 — trading 53.7% above its estimated fair value. The current GF Score is 75, which is near median its 10-year median of 70.00. Veracyte's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Veracyte (VCYT), the current GF Score is 75 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Veracyte (VCYT) Overvalued in 2026?

Based on GuruFocus' analysis, Veracyte stock appears to be overvalued. The current stock price of $58.59 is trading 53.7% above its estimated GF Value™ of $38.11. GuruFocus considers Veracyte to be Significantly Overvalued.

Key valuation signals for VCYT:

  • GF Score: 75 (near median its 10-year median of 70.00)
  • GF Value™: $38.11 vs. price of $58.59 (53.7% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the VCYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Veracyte Business Description

Other Exchanges 12V:Germany
Address 6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
75GF Score

Get the complete analysis for VCYT

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$58.59
Price
$38.11
GF Value